293 related articles for article (PubMed ID: 15936573)
1. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice.
Dörr W; Bässler S; Reichel S; Spekl K
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):881-7. PubMed ID: 15936573
[TBL] [Abstract][Full Text] [Related]
2. Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation.
Dörr W; Reichel S; Spekl K
Radiother Oncol; 2005 Apr; 75(1):99-105. PubMed ID: 15878107
[TBL] [Abstract][Full Text] [Related]
3. Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF.
Dörr W; Heider K; Spekl K
Int J Radiat Biol; 2005 Aug; 81(8):557-65. PubMed ID: 16298937
[TBL] [Abstract][Full Text] [Related]
4. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa.
Gehrisch A; Dörr W
Strahlenther Onkol; 2007 Jan; 183(1):36-42. PubMed ID: 17225944
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine.
Fleischer G; Dörr W
Strahlenther Onkol; 2006 Oct; 182(10):567-75. PubMed ID: 17013569
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human keratinocyte growth factor (rHuKGF, Palifermin) on radiation-induced mouse urinary bladder dysfunction.
Jaal J; Dörr W
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):528-33. PubMed ID: 17869665
[TBL] [Abstract][Full Text] [Related]
7. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of acute oral mucositis by keratinocyte growth factor: fractionated irradiation.
Dörr W; Spekl K; Farrell CL
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):245-51. PubMed ID: 12182998
[TBL] [Abstract][Full Text] [Related]
9. Effects of dexpanthenol with or without Aloe vera extract on radiation-induced oral mucositis: preclinical studies.
Dörr W; Schlichting S; Bray MA; Flockhart IR; Hopewell JW
Int J Radiat Biol; 2005 Mar; 81(3):243-50. PubMed ID: 16019933
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
11. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
[TBL] [Abstract][Full Text] [Related]
12. Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies.
Haagen J; Krohn H; Röllig S; Schmidt M; Wolfram K; Dörr W
Radiother Oncol; 2009 Sep; 92(3):472-6. PubMed ID: 19576646
[TBL] [Abstract][Full Text] [Related]
13. Effect of post-exposure administration of keratinocyte growth factor (Palifermin) on radiation effects in oral mucosa in mice.
Kiliç Y; Rajewski K; Dörr W
Radiat Environ Biophys; 2007 Mar; 46(1):13-9. PubMed ID: 17103218
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats.
Chen L; Brizel DM; Rabbani ZN; Samulski TV; Farrell CL; Larrier N; Anscher MS; Vujaskovic Z
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1520-9. PubMed ID: 15590184
[TBL] [Abstract][Full Text] [Related]
15. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
[TBL] [Abstract][Full Text] [Related]
16. A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis.
Borges L; Rex KL; Chen JN; Wei P; Kaufman S; Scully S; Pretorius JK; Farrell CL
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):254-62. PubMed ID: 16904525
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the hamster cheek pouch as a model for radiation-induced oral mucositis, and evaluation of the protective effects of keratinocyte growth factor using this model.
Watanabe S; Suemaru K; Nakanishi M; Nakajima N; Tanaka M; Tanaka A; Araki H
Int J Radiat Biol; 2014 Oct; 90(10):884-91. PubMed ID: 24827853
[TBL] [Abstract][Full Text] [Related]
18. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human keratinocyte growth factor (Δ23rHuKGF, Palifermin) on inflammatory and immune changes in mouse tongue during fractionated irradiation.
Jaal J; Richter C; Dörr W
Int J Radiat Biol; 2010 Oct; 86(10):860-6. PubMed ID: 20636237
[TBL] [Abstract][Full Text] [Related]
20. Modulation of radiation-induced oral mucositis (mouse) by selective inhibition of β1 integrin.
Albert M; Schmidt M; Cordes N; Dörr W
Radiother Oncol; 2012 Aug; 104(2):230-4. PubMed ID: 22841020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
